3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
Nivolumab
6
pembrolizumab
3
Ipilimumab
3
relatlimab
2
cemiplimab
2
Specimen Handling
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
vedolizumab
1
trametinib
1
toripalimab
1
sulforaphane
1
gadopiclenol
1
famitinib
1
anlotinib
1
X-Rays
1
Watchful Waiting
1
Toll-Like Receptor 1
1
Therapeutics
1
Temozolomide
1
Technetium
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
SHR-1701
1
Rehabilitation
1
Photopheresis
1
Pemetrexed
1
Paclitaxel
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Melanoma
×
vedolizumab
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled